Progress in Drug Research

Lieferzeit: Lieferbar innerhalb 14 Tagen

213,99 

Progress in Drug Research 58

ISBN: 3034894686
ISBN 13: 9783034894685
Herausgeber: Ernst M Jucker
Verlag: Springer Basel AG
Umfang: viii, 324 S., 52 s/w Illustr.
Erscheinungsdatum: 29.10.2012
Auflage: 1/2002
Produktform: Kartoniert
Einband: KT

InhaltsangabeDrugs, the human genome, and individual-based medicine.- Herbal medicine of Wisconsin Indians.- The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery.- Potassium channels: Gene family, therapeutic relevance, high-throughput screening technologies and drug discovery.- Dual serotonin and noradrenaline uptake inhibitor class of antidepressants – Potential for greater efficacy or just hype?.- Advances in QSAR studies of HIV-1 reverse transcriptase inhibitors.- Index Vol. 58.- Index of titles, Vol. 1-58.- Author and paper index, Vol. 1-58.

Artikelnummer: 5524141 Kategorie:

Beschreibung

Jay A. Glasel: Drugs, the human genome, and individual-based medicine.- Vera M. Kolb: Herbal medicine of Wisconsin Indians.- Paul L. Skatrud: The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery.- John W. Ford, Edward B. Stevens, J. Mark Treherne, Jeremy Packer and Mark Bushfield: Potassium channels: Gene family, therapeutic relevance, high-throughput screening technologies and drug discovery. David T. Wong and Frank P. Bymaster: Dual serotonin and noradrenaline uptake inhibitor class of antidepressants - Potential for greater efficacy of just hype?.- Satya P. Gupta: Advances in QSAR studies of HIV-1 reverse transcriptase inhibitors

Autorenporträt

InhaltsangabeDrugs, the human genome, and individual-based medicine.- Herbal medicine of Wisconsin Indians.- The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery.- Potassium channels: Gene family, therapeutic relevance, high-throughput screening technologies and drug discovery.- Dual serotonin and noradrenaline uptake inhibitor class of antidepressants - Potential for greater efficacy or just hype?.- Advances in QSAR studies of HIV-1 reverse transcriptase inhibitors.- Index Vol. 58.- Index of titles, Vol. 1-58.- Author and paper index, Vol. 1-58.

Das könnte Ihnen auch gefallen …